2025 annual financial data
Cullinan Therapeutics 2025 Net income growth
Direct answer
Net income growth was -31.36%.
Operating income was -241,648,000 USD and net income was -219,879,000 USD.
Operating cash flow was -175,750,000 USD.
Get free Cullinan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -241,648,000 USD
- Net income
- -219,879,000 USD
- Operating cash flow
- -175,750,000 USD